Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis
Table 1
The potential role of the CX3CL1/CX3CR1 signaling axis in osteoclastogenesis. OCs: osteoclasts; OBs: osteoblasts; BMCs: bone marrow cells; CD: cluster of differentiation; CXCR4: CXC chemokine receptor type 4; BMD: bone mineral density; CSF1R: colony-stimulating factor 1 receptor; EGFP: enhanced green fluorescent protein; CX3CR1: CX3C chemokine receptor 1; LPA: lysophosphatidic acid; LPAR1: lysophosphatidic acid receptor type 1; BMMs: bone marrow macrophages; CX3CL1: CX3C motif chemokine ligand 1; PMOP: postmenopausal osteoporosis patients; PMNOP: healthy postmenopausal patients; TRACP-5b: tartrate-resistant acid phosphatase 5b; NTx: cross-linked N-telopeptides of type I collagen; IL-1β: interleukin 1 beta; IL-6: interleukin 6.
Study
Material
CX3CL1/CX3CR1 axis role
Koizumi et al.
(i) Mouse precursors of OCs (Toyama, Japan) (ii) Mouse OBs (Toyama, Japan) (iii) Mature OCs (Wako Pure Chemical) (iv) Bone samples of orthopedic patients (University of Toyama, Toyama, Japan)
(i) Stimulation of differentiation of OC precursors into mature OCs (ii) Activation of local inflammatory reaction and migration of monocytes/macrophages to bone tissue (iii) Cofactor for the OC maturation and OB binding
(i) Promotion of osteoclastogenesis (ii) Bone resorption and BMD reduction (iii) Activation and fusion of OCs in the formation of multijugular forms
Kikuta et al.
(i) CD11b+ cells from C57BL/6 mice (CREA Japan) (ii) BMCs from CSF1R-EGFP+ transgenic mice (Jackson Laboratory) (iii) BMCs from CX3CR1-EGFP+ knock-in mice (Jackson Laboratory) (iv) Mouse RAW264.7 cells (Chugai Pharmaceuticals Co., Ltd.)
(i) Stimulation of mobility of CX3CR1-EGFP+ cells near bone tissue
David et al.
(i) BMCs from CX3CR1-EGFP+ knock-in mice (Jackson Laboratory)
(i) Potential correlation with LPA/LPAR1 in promoting osteoclastogenesis process
Song et al.
(i) BMMs from C57BL/6 mice (CREA Japan)
(i) Induction of inflammatory processes and osteoclastogenesis
Chen et al.
Concentration of CX3CL1 in blood serum in group of (i) 53 PMOP (ii) 51 PMNOP (iii) 50 healthy premenopausal patients
(i) Increasing the concentration of bone turnover markers (TRACP-5b, NTx) and inflammatory factors (IL-1β, IL-6) in blood serum (ii) Potential marker and screening test of the exacerbation of osteoporotic lesions